Clinical Research
Valvular Heart Disease
Usefulness of the Valvuloarterial Impedance to Predict Adverse Outcome in Asymptomatic Aortic Stenosis

https://doi.org/10.1016/j.jacc.2009.04.079Get rights and content
Under an Elsevier user license
open archive

Objectives

This study was designed to examine the prognostic value of valvuloarterial impedance (Zva) in patients with aortic stenosis (AS).

Background

We previously showed that the Zvais superior to standard indexes of AS severity in estimating the global hemodynamic load faced by the left ventricle (LV) and predicting the occurrence of LV dysfunction. This index is calculated by dividing the estimated LV systolic pressure (systolic arterial pressure + mean transvalvular gradient) by the stroke volume indexed for the body surface area.

Methods

We retrospectively analyzed the clinical and echocardiographic data of 544 consecutive patients having at least moderate AS (aortic jet velocity ≥2.5 m·s−1) and no symptoms at baseline. The primary end point for this study was the overall mortality regardless of the realization of aortic valve replacement (AVR).

Results

Four-year survival was significantly (p < 0.001) lower in the patients with a baseline Zva≥4.5 mm Hg·ml−1·m2(65 ± 5%) compared with those with Zvabetween 3.5 and 4.5 mm Hg·ml−1·m2(78 ± 4%) and those with Zva≤3.5 mm Hg·ml−1·m2(88 ± 3%). The risk of mortality was increased by 2.76-fold in patients with Zva≥4.5 mm Hg·ml−1·m2and by 2.30-fold in those with a Zvabetween 3.5 and 4.5 mm Hg·ml−1·m2after adjusting for other risk factors and type of treatment (surgical vs. medical).

Conclusions

Increased Zvais a marker of excessive LV hemodynamic load, and a value >3.5 successfully identifies patients with a poor outcome. These findings suggest that beyond standard indexes of stenosis severity, the consideration of Zvamay be useful to improve risk stratification and clinical decision making in patients with AS.

Key Words

aortic valve
aortic stenosis
hypertension
arterial compliance
mortality

Abbreviations and Acronyms

AS
aortic stenosis
AVA
aortic valve area
AVR
aortic valve replacement
CABG
coronary artery bypass graft
CI
confidence interval
ELI
energy loss index
LV
left ventricle/ventricular
LVEF
left ventricular ejection fraction
PP
pulse pressure
SV
stroke volume
SVI
stroke volume index
Zva
valvuloarterial impedance

Cited by (0)

This work was supported by a grant from the Canadian Institutes of Health Research (MOP-82873), Ottawa, Canada.

Dr. Pibarot holds the Canada Research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada.